HOYA Corporation (TYO:7741)
Japan
· Delayed Price · Currency is JPY 23,900
+60 (0.25%)
At close: Dec 5, 2025
HOYA Corporation Revenue
HOYA Corporation had revenue of 234.02B JPY in the quarter ending September 30, 2025, with 9.02% growth. This brings the company's revenue in the last twelve months to 892.50B, up 9.81% year-over-year. In the fiscal year ending March 31, 2025, HOYA Corporation had annual revenue of 866.03B with 13.56% growth.
Revenue (ttm)
892.50B
Revenue Growth
+9.81%
P/S Ratio
9.06
Revenue / Employee
23.54M
Employees
37,909
Market Cap
8,087.06B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 866.03B | 103.42B | 13.56% |
| Mar 31, 2024 | 762.61B | 39.03B | 5.39% |
| Mar 31, 2023 | 723.58B | 62.12B | 9.39% |
| Mar 31, 2022 | 661.47B | 113.55B | 20.72% |
| Mar 31, 2021 | 547.92B | -28.63B | -4.96% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,213.71B |
| Takeda Pharmaceutical Company | 4,417.00B |
| Daiichi Sankyo Company | 1,978.88B |
| Otsuka Holdings | 2,418.53B |
| Astellas Pharma | 2,006.82B |
| Terumo | 1,062.42B |
| Shionogi & | 437.26B |
| Olympus | 977.65B |